Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)801-802
Number of pages2
JournalJournal of Clinical Investigation
Volume108
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Animal Disease Models
Epstein-Barr Virus Infections
SCID Mice
Lymphoproliferative Disorders
Granulocyte-Macrophage Colony-Stimulating Factor
Human Herpesvirus 4
Natural Killer Cells
Immunotherapy
Interleukin-2

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{a692909d686446ac966c69cba249fd93,
title = "Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?",
author = "Michael Robertson",
year = "2001",
doi = "10.1172/JCI200114003",
language = "English",
volume = "108",
pages = "801--802",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

AU - Robertson, Michael

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0034836938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034836938&partnerID=8YFLogxK

U2 - 10.1172/JCI200114003

DO - 10.1172/JCI200114003

M3 - Article

VL - 108

SP - 801

EP - 802

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -